Mind Medicine (Mind Medicine) Equity-to-Asset : 0.63 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mind Medicine's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $78.13 Mil. Mind Medicine's Total Assets for the quarter that ended in Dec. 2023 was $124.54 Mil.

The historical rank and industry rank for Mind Medicine's Equity-to-Asset or its related term are showing as below:

MMCWF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.63 Med: 0.91 Max: 0.93
Current: 0.63

During the past 4 years, the highest Equity to Asset Ratio of Mind Medicine was 0.93. The lowest was 0.63. And the median was 0.91.

MMCWF's Equity-to-Asset is ranked worse than
52.71% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs MMCWF: 0.63

Mind Medicine Equity-to-Asset Historical Data

The historical data trend for Mind Medicine's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Equity-to-Asset Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.93

0.89

0.63

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial												0.89	0.84	0.75	0.68	0.63

Competitive Comparison of Mind Medicine's Equity-to-Asset

For the Biotechnology subindustry, Mind Medicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mind Medicine's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mind Medicine's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Mind Medicine's Equity-to-Asset falls into.

Mind Medicine Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Mind Medicine's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	78.134	/	124.541
	=

Mind Medicine's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	78.134	/	124.541
	=

Mind Medicine (OTCPK:MMCWF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Mind Medicine Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (Mind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.